Targeted Protein Degradation
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
141
NCT06994572
Study of CT-01 as Monotherapy and Combination Therapy in Subjects With Intermediate or Advanced Hepatocellular Carcinoma
Phase: Phase 1
Role: Lead Sponsor
Start: May 26, 2025
Completion: Apr 1, 2030
Loading map...